Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin
Research ArticleClinical Studies

A Randomized Trial to Compare the Efficacy and Safety of Antiemetic Treatment with Ondansetron and Ondansetron Zydis in Patients with Breast Cancer Treated with High-dose Epirubicin

D. PECTASIDES, U. DAFNI, G. ARAVANTINOS, E. TIMOTHEADOU, D.V. SKARLOS, N. PAVLIDIS, A. GAGLIA, H.P. KALOFONOS and G. FOUNTZILAS
Anticancer Research November 2007, 27 (6C) 4411-4417;
D. PECTASIDES
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: pectasid@otenet.gr
U. DAFNI
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
G. ARAVANTINOS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
E. TIMOTHEADOU
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
D.V. SKARLOS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
N. PAVLIDIS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
A. GAGLIA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
H.P. KALOFONOS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
G. FOUNTZILAS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 27 no. 6C 4411-4417
PubMed 
18214053

Published By 
International Institute of Anticancer Research
Print ISSN 
0250-7005
Online ISSN 
1791-7530
History 
  • Received June 20, 2007
  • Revision received September 11, 2007
  • Accepted October 8, 2007
  • Published online November 1, 2007.

Copyright & Usage 
Copyright© 2007 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved

Author Information

  1. D. PECTASIDES1,
  2. U. DAFNI2,
  3. G. ARAVANTINOS3,
  4. E. TIMOTHEADOU4,
  5. D.V. SKARLOS5,
  6. N. PAVLIDIS6,
  7. A. GAGLIA1,
  8. H.P. KALOFONOS7 and
  9. G. FOUNTZILAS4
  1. 1Second Department of Internal Medicine, Oncology Section, Attikon University General Hospital Haidari, Athens
  2. 2Laboratory of Biostatistics, University of Athens School of Nursing, Athens
  3. 3Third Department of Medical Oncology, Agii Anargiri Cancer Hospital, Athens
  4. 4Department of Medical Oncology, Papageorgiou General Hospital, Aristotle University of Thessaloniki School of Medicine, Thessaloniki
  5. 5Second Department of Medical Oncology, Henry Dunant Hospital, Athens
  6. 6Department of Medical Oncology, Ioannina University Hospital, Ioannina
  7. 7Department of Medicine, Division of Oncology, University Hospital of Patras, Greece
  1. Correspondence to: D. Pectasides, Second Department of Internal Medicine, Propaedeutic, Oncology Section, Attikon University Hospital, Rimini 1, Haidari, Athens, Greece. Tel: +30 210 5831691, +30 210 6008610, Fax: +30 210 5831690, +30 210 6008610, e-mail: pectasid{at}otenet.gr

Cited By...

  • 3 Citations
  • Google Scholar
PreviousNext
Back to top

In this issue

Anticancer Research: 27 (6C)
Anticancer Research
Vol. 27, Issue 6C
November-December 2007
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Anticancer Research.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
A Randomized Trial to Compare the Efficacy and Safety of Antiemetic Treatment with Ondansetron and Ondansetron Zydis in Patients with Breast Cancer Treated with High-dose Epirubicin
(Your Name) has sent you a message from Anticancer Research
(Your Name) thought you would like to see the Anticancer Research web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
6 + 2 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
A Randomized Trial to Compare the Efficacy and Safety of Antiemetic Treatment with Ondansetron and Ondansetron Zydis in Patients with Breast Cancer Treated with High-dose Epirubicin
D. PECTASIDES, U. DAFNI, G. ARAVANTINOS, E. TIMOTHEADOU, D.V. SKARLOS, N. PAVLIDIS, A. GAGLIA, H.P. KALOFONOS, G. FOUNTZILAS
Anticancer Research Nov 2007, 27 (6C) 4411-4417;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
A Randomized Trial to Compare the Efficacy and Safety of Antiemetic Treatment with Ondansetron and Ondansetron Zydis in Patients with Breast Cancer Treated with High-dose Epirubicin
D. PECTASIDES, U. DAFNI, G. ARAVANTINOS, E. TIMOTHEADOU, D.V. SKARLOS, N. PAVLIDIS, A. GAGLIA, H.P. KALOFONOS, G. FOUNTZILAS
Anticancer Research Nov 2007, 27 (6C) 4411-4417;
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • Antiemetics: American Society of Clinical Oncology Clinical Practice Guideline Update
  • Google Scholar

More in this TOC Section

  • Pelvic Recurrence After Curative Resection for Rectal Adenocarcinoma: Impact of Surgery on Survival
  • Glasgow Prognostic Score Predicts Survival and Recurrence Pattern in Patients With Hepatocellular Carcinoma After Hepatectomy
  • Small Bowel Lipomatosis: An Unusual Radiological Finding in Patients With Renal Cell Cancer on Pazopanib
Show more Clinical Studies

Similar Articles

Anticancer Research

© 2023 Anticancer Research

Powered by HighWire